Inovio Pharmaceuticals (INO) Change in Intangibles (2012 - 2017)
Inovio Pharmaceuticals (INO) posted Change in Intangibles of $1.0 million for Q4 2017, little changed sequentially from $1.0 million in Q4 2013.
Inovio Pharmaceuticals (INO) Change in Intangibles (2012 - 2017) Analysis & Trends
Inovio Pharmaceuticals has reported Change in Intangibles for 3 years, with the latest figure at $1.0 million in Q4 2017.
- Quarterly Change in Intangibles changed N/A year-over-year to $1.0 million in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $1.0 million (changed N/A YoY) and the FY2017 annual result came in at $1.0 million, changed 0.0% from the prior year.
- Change in Intangibles held at $1.0 million in Q4 2017 per INO's latest filing, from $1.0 million in the prior quarter.
- Over five years, Change in Intangibles peaked at $1.0 million in Q2 2013 and troughed at $1.0 million in Q2 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.68 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Inovio Pharmaceuticals | 96.32 Mn | 96.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 1.00 Mn |
| Dec 31, 2017 | 1.00 Mn |
| Dec 31, 2013 | 1.00 Mn |
| Dec 31, 2013 | 1.00 Mn |
| Jun 30, 2013 | 1.00 Mn |
| Jun 30, 2013 | 1.00 Mn |
| Sep 30, 2012 | 500,000.00 |
| Sep 30, 2012 | 500,000.00 |
| Mar 31, 2012 | 150,000.00 |
| Mar 31, 2012 | 150,000.00 |